Is Teleflex Incorporated (TFX) overvalued? · P/E 2083, rev $3.05B
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
This page asks whether Teleflex Incorporated (TFX) looks expensive on cached numbers — not a short thesis.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TFX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TFX stock page for the full model, not this heading.
Not investment advice.